Ovomucoid: Market outlook

The avoidance of animal-derived food ingredients to support animal movement cruelty movement over the past few years has led food manufacturers to think and invest more in R&D to deduce some solution and cater the demand of their customer with utmost satisfaction. The most commonly used protease inhibitor is fetal calf serum and it has been revealed that there is a risk of zoonosis i.e. the transfer of disease from animal to human beings. Over the past few decades, there have been several cases of mad cow disease has been suspected after the consumption of bovine-derived proteins. Ovomucoid is egg white protein and functions effectively as a protease inhibitor, opening their way for its application in the food processing industry. Urbanization and hectic life schedule are fuelling the demand for processed and ready-to-eat food products, which directly increases the demand for ovomucoid over the coming years. Ovomucoid can be added during food processing to prevent over-hydrolysis from protein-degrading enzymes. On the other hand, ovomucoid is also gaining its popularity among the researchers and scientists as it works efficiently in cell harvesting and tissue dissociation during cell culture and tissue culture respectively. In the global ovomucoid market, North America and Europe hold the major share in production and consumption of ovomucoid owing to the presence of key food processing companies in the region. In addition, the presence of various world-class research laboratories and life science companies in the region. It can be anticipated that the demand for ovomucoid will increase in the food processing industry and life science industry owing to the rising demand for ready-to-eat products and growth in life science research.

Rising Demand for Ovomucoid in Food industry and Research Organizations

Ovomucoid is generally used in the life science research laboratories, to harvest the cells by breaking the connection between them. The cells are attached to other cells with the help of connectin protein, and it has to be broke for passaging of cells. In order to give passage, generally trypsin is used to break the connection of cells and after some time, protease inhibiting proteins are added to restrict the activity of proteolysis. Bovine Serum Albumin is generally used to stop the activity of trypsin. But many researchers and scientist are supporting the non-cruelty of animals and opting for alternative protein sources to stop their activity. Ovomucoid has proved their effectiveness and many research laboratories are opting for ovomucoid for their research purpose. Ovomucoid is generally obtained by the traditional method instead of an invasive method applied to obtain bovine serum protein. In addition, it also prevents cell damage and cell death after the harvest of cells during cell culture. Ovomucoid is also used in protein isolation process where it prevents protein degradation. The demand for ovomucoid is also increasing in the food processing industry, as it prevents the breakdown of proteins present in the food products. With the increasing demand of ovomucoid in various sectors, it is expected that the demand of ovomucoid will increase over the forecast period.

Global Ovomucoid: Market Segmentation

On the basis of grade, global Ovomucoid market is segmented as

  • Food Grade
  • Industrial Grade

On the basis of end use, global Ovomucoid market is segmented as

  • Food Industry
  • Research Laboratory

Global Ovomucoid: Key Players

Some of the key players operating their business in the ovomucoid market are Neova Technologies Inc., Merck KGaA, Separation Methods Technologies, Inc. and others. Many other players are showing their keen interest to bring ovomucoid in their production line. 

Opportunities for Market Participants:

Increasing health and wellness among consumers has increased the demand for protein supplements among the consumer. The proteins are isolated on large columns on an industrial scale where there is the use of protease inhibitor to prevent the degradation of the protein. Ovomucoid is an efficient protease inhibitor which can be used in the column to prevent the degradation of the target protein. Apart from all the above-mentioned factors, increasing awareness about ovomucoid among the manufacturers and researchers is propelling the demand of ovomuciod and it is expected that the demand of ovomucoid will increase in the coming future.

The Ovomucoid market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the Ovomucoid market, including but not limited to: regional markets grade, end use.

The study is a source of reliable data on:

  • Ovomucoid market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa) 

The Ovomucoid market report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the Ovomucoid market report projects the attractiveness of each major segment over the forecast period.

Highlights of the Ovomucoid market report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the Ovomucoid market
  • Recommendations to companies for strengthening their foothold in the Ovomucoid market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

.